Value of surveillance imaging in the management of medulloblastoma

Medical and Pediatric Oncology

Volumn 38, Issue 2, 2002, Pages 91-97

  Akyüz, Canan ^a   Kutluk, M Tezer ^a   Büyükpamukçu, Münevver ^a   Yalçın, Bilgehan ^a   Akalan, Nejat ^a   Cila, Ayşenur ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

Childhood cancer; Computerized tomography; Magnetic resonance imaging; Medulloblastoma; Surveillance

Indexed keywords

ARTICLE; CANCER DIAGNOSIS; CANCER RECURRENCE; CANCER SURVIVAL; CHILD; CHILDHOOD CANCER; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDULLOBLASTOMA; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL;

ADOLESCENT; CEREBELLAR NEOPLASMS; CHILD; CHILD, PRESCHOOL; COST-BENEFIT ANALYSIS; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; INFANT; MAGNETIC RESONANCE IMAGING; MALE; MEDULLOBLASTOMA; NEOPLASM RECURRENCE, LOCAL; RETROSPECTIVE STUDIES; SURVIVAL RATE; TOMOGRAPHY, X-RAY COMPUTED; TURKEY;

EID: 0036158253     PISSN: 00981532     EISSN: None     Source Type: Journal    
DOI: 10.1002/mpo.1278     Document Type: Article

References (30)

1. The continued surveillance for medulloblastoma: Primitive neuroectodermal tumors
2. Surveillance scanning of children with medulloblastoma
3. Surveillance scanning of children with medulloblastoma
4. More on surveillance of children with medulloblastoma
5. Surveillance imaging in children with primitive neuroectodermal tumors
6. Value of postoperative surveillance imaging in the management of children with some common brain tumors
7. Asymptomatic recurrence detection with surveillance scanning in children with medulloblastoma
8. Improving survival in recurrent medulloblastoma: Earlier detection, better treatment or still an impasse?
9. Surveillance imaging in children with medulloblastoma (posterior fossa PNET)
10. Non-parametric estimation from incomplete observations
11. Design and analysis of randomized clinical trials requiring prolonged observation of each patient
12. The treatment of medulloblastoma. Results of a prospective randomized trial of radiation therapy with and without CCNU, vincristine, and prednisone
13. Prospective randomised trial of chemotherapy given before radiotherapy in childhood medulloblastoma
14. Medulloblastoma: Is the 5-year survival rate improving?
15. Medulloblastoma: Freedom from relapse longer than 8 years - A therapeutic cure?
16. Central nervous system malignancies
17. The value of surveillance testing in childhood brain tumors
18. Staging and surveillance of children with central nervous system neoplasms: Recommendations of the Neurology and Tumor Imaging Committees of the Children's Cancer Group
19. Recurrence of medulloblastoma: Violation of Collins' law after two decades
20. Importance of patient evaluation for long-term survival in medulloblastoma recurrence
21. Recurrence of medulloblastoma 19 years after the initial diagnosis
22. Cancer screening
23. Cure of recurrent medulloblastoma: The contribution of surgical resection at relapse
24. Will high dose chemotherapy followed by autologous bone marrow transplantation supplant cranio-spinal irradiation in young children treated for medulloblastoma?
25. High-dose chemotherapy with autologous stem-cell rescue in children with recurrent and high-risk pediatric brain tumors
26. The role of high-dose chemotherapy and stem cell rescue in the treatment of malignant brain tumors: A reappraisal
27. Betulinic acid: A new cytotoxic agent against malignant brain-tumor cells
28. Monoclonal antibody therapy of human gliomas: Current status and future approaches
29. Gene therapy for the treatment of recurrent pediatric malignant astrocytomas with in vivo tumor transduction with the herpes simplex thymidine kinase/gancyclovir system
30. Results of radiosurgery in the management of recurrent and residual medulloblastoma